Author:
Lu Y,Kitaura J,Oki T,Komeno Y,Ozaki K,Kiyono M,Kumagai H,Nakajima H,Nosaka T,Aburatani H,Kitamura T
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference51 articles.
1. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR . A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991; 65: 1143–1152.
2. Rosnet O, Marchetto S, deLapeyriere O, Birnbaum D . Oncogene 1991; 6: 1641–1650.
3. Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P et al. STK-1, the human homolog of Flk-2/Flt3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 1994; 91: 459–463.
4. Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D et al. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 1996; 10: 238–248.
5. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR . Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995; 3: 147–161.